Trial intelligence / Profile preview

TFP Block for Post-Cesarean Analgesia

NCT04172727Phase 4Completed

Sponsor
Atatürk University
Start
Jan 2019
Primary completion
May 2019
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial of bupivacaine in postoperative pain (2 arms), sponsored by Atatürk University. Primary endpoint: Postoperative opioid consumption at 24 hours. Started Jan 2019; status: completed.

02

Drugs

bupivacaine
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT04172727.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04172727.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call